Cigarette smoking, a major
stroke risk factor, upregulates
endothelin receptors in cerebral arteries. The present study examined the effects of MEK1/2 pathway inhibition on cigarette
smoke exposure-induced ET receptor upregulation. Rats were exposed to the
secondhand smoke (SHS) for 8weeks followed by
intraperitoneal injection of MEK1/2 inhibitor,
U0126 for another 4weeks. The urine
cotinine levels were assessed with high-performance liquid chromatography. Contractile responses of isolated cerebral arteries were recorded by a sensitive wire myograph. The
mRNA and
protein expression levels of receptor and
MEK/ERK1/2 pathway molecules were examined by real-time PCR and Western blotting, respectively. Cerebral artery receptor localization was determined with immunohistochemistry. The results showed the urine
cotinine levels from SHS exposure group were significantly higher than those from the fresh group. In addition, the MEK1/2 inhibitor,
U0126 significantly reduced SHS exposure-increased ETA receptor
mRNA and
protein levels as well as contractile responses mediated by ETA receptors. The immunoreactivity of increased ETA receptor expression was primarily cytoplasmic in smooth muscle cells. In contrast, ETB receptor was noted in endothelial cells. However, the SHS-induced decrease in endothelium-dependent relaxation was unchanged after
U0126 treatment. Furthermore, SHS increased the phosphorylation of MEK1/2 and ERK1/2
protein in cerebral arteries. By using
U0126 could inhibit the phosphorylated ERK1/2
protein but not MEK1/2. Taken together, our data show that treatment with MEK1/2 pathway inhibitor offsets SHS exposure-induced ETA receptor upregulation in rat cerebral arteries.